Literature DB >> 21451997

Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders.

Sandip Basu, Thomas C Kwee, Robert Gatenby, Babak Saboury, Drew A Torigian, Abass Alavi.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21451997     DOI： 10.1007/s00259-011-1787-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  27 in total

Review 1.  Mechanisms of tumor progression.

Authors:  P C Nowell
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

Review 2.  Clinical implications of tumor heterogeneity.

Authors:  R L Schilsky
Journal:  Haematol Blood Transfus       Date:  1987

3.  Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.

Authors:  W Wang; S M Larson; M Fazzari; S K Tickoo; K Kolbert; G Sgouros; H Yeung; H Macapinlac; J Rosai; R J Robbins
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

4.  Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder.

Authors:  S Krüger; C Thorns; A Böhle; A C Feller
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

5.  Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors.

Authors:  Etienne Garin; Florence Le Jeune; Anne Devillers; Marc Cuggia; Anne-Sophie de Lajarte-Thirouard; Catherine Bouriel; Eveline Boucher; Jean-Luc Raoul
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

6.  Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry.

Authors:  Donald J Johann; Jaime Rodriguez-Canales; Sumana Mukherjee; DaRue A Prieto; Jeffrey C Hanson; Michael Emmert-Buck; Josip Blonder
Journal:  J Proteome Res       Date:  2009-05       Impact factor: 4.466

Review 7.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

8.  Tumor metabolism measured by partial volume corrected standardized uptake value varies considerably in primary and metastatic sites in patients with lung cancer. A new observation.

Authors:  Gonca Bural; Drew A Torigian; Mohamed Houseni; Sandip Basu; Shyam Srinivas; Abass Alavi
Journal:  Hell J Nucl Med       Date:  2009 Sep-Dec       Impact factor: 1.102

9.  Application of information theory and extreme physical information to carcinogenesis.

Authors:  Robert A Gatenby; B Roy Frieden
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

10.  18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors.

Authors:  Tina Binderup; Ulrich Knigge; Annika Loft; Birgitte Federspiel; Andreas Kjaer
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531
View more
  40 in total

1.  Nuclear medicine, scientific publishing and the era of cost containment: what factors hold the key?

Authors:  Sandip Basu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-14       Impact factor: 9.236

2.  18F-FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma.

Authors:  James C Davis; Najat C Daw; Fariba Navid; Catherine A Billups; Jianrong Wu; Armita Bahrami; Jesse J Jenkins; Scott E Snyder; Wilburn E Reddick; Victor M Santana; M Beth McCarville; Junyu Guo; Barry L Shulkin
Journal:  J Nucl Med       Date:  2017-06-13       Impact factor: 10.057

3.  AI-based applications in hybrid imaging: how to build smart and truly multi-parametric decision models for radiomics.

Authors:  Isabella Castiglioni; Francesca Gallivanone; Paolo Soda; Michele Avanzo; Joseph Stancanello; Marco Aiello; Matteo Interlenghi; Marco Salvatore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-11       Impact factor: 9.236

4.  Preoperative prediction of regional lymph node metastasis of colorectal cancer based on 18F-FDG PET/CT and machine learning.

Authors:  Jiahong He; Quanshi Wang; Yin Zhang; Hubing Wu; Yongsheng Zhou; Shuangquan Zhao
Journal:  Ann Nucl Med       Date:  2021-03-18       Impact factor: 2.668

5.  Intraindividual tumor heterogeneity in NET - Further insight by C-X-C motif chemokine receptor 4-directed imaging.

Authors:  Rudolf A Werner; Alexander Weich; Andreas Schirbel; Samuel Samnick; Andreas K Buck; Takahiro Higuchi; Hans-Jürgen Wester; Constantin Lapa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-11-09       Impact factor: 9.236

6.  Dual tracer imaging approach in assessing tumor biology and heterogeneity in neuroendocrine tumors: its correlation with tumor proliferation index and possible multifaceted implications for personalized clinical management decisions, with focus on PRRT.

Authors:  Sandip Basu; Bhawna Sirohi; Shailesh V Shrikhande
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-27       Impact factor: 9.236

7.  Prognostic value of preoperative intratumoral FDG uptake heterogeneity in patients with epithelial ovarian cancer.

Authors:  Maria Lee; Hyunjong Lee; Gi Jeong Cheon; Hee Seung Kim; Hyun Hoon Chung; Jae-Weon Kim; Noh-Hyun Park; Yong Sang Song
Journal:  Eur Radiol       Date:  2016-04-27       Impact factor: 5.315

Review 8.  Characterization of PET/CT images using texture analysis: the past, the present… any future?

Authors:  Mathieu Hatt; Florent Tixier; Larry Pierce; Paul E Kinahan; Catherine Cheze Le Rest; Dimitris Visvikis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-06       Impact factor: 9.236

9.  Value of 18F-FDG heterogeneity for discerning metastatic from benign lymph nodes in nasopharyngeal carcinoma patients with suspected recurrence.

Authors:  Seung Hwan Moon; Young Seok Cho; Young-Ik Son; Yong Chan Ahn; Myung-Ju Ahn; Joon Young Choi; Byung-Tae Kim; Kyung-Han Lee
Journal:  Br J Radiol       Date:  2016-09-21       Impact factor: 3.039

10.  Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

Authors:  David Groheux; Mohamed Majdoub; Florent Tixier; Catherine Cheze Le Rest; Antoine Martineau; Pascal Merlet; Marc Espié; Anne de Roquancourt; Elif Hindié; Mathieu Hatt; Dimitris Visvikis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-04       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.